For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250210:nRSJ5531Wa&default-theme=true
RNS Number : 5531W Polar Capital Global Health Tst PLC 10 February 2025
10(th) February 2025
Polar Capital Global Healthcare Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 31(st)
January 2025, full Portfolio listing as at 31(st) December 2024 available from
company's website.
Polar Capital Global Healthcare Trust plc is pleased to announce that as at
31(st) January 2025 the top ten equity holdings and the sector and geographic
breakdown were as follows:
Top 10 Holdings %
UnitedHealth Group 8.4%
Eli Lilly & Co 7.3%
Novo Nordisk A/S 4.8%
Abbott Laboratories 4.7%
Intuitive Surgical 3.6%
Terumo Corp 3.5%
Fresenius SE & Co KGaA 3.5%
Sanofi 3.5%
Roche 3.5%
UCB 3.3%
Total 46.0%
Sector Exposure %
Pharmaceuticals 27.3%
Healthcare Equipment 25.3%
Biotechnology 15.2%
Managed Healthcare 8.4%
Life Sciences Tools & Services 6.9%
Healthcare Supplies 4.8%
Healthcare Services 3.5%
Healthcare Technology 2.5%
Metal, Glass & Plastic Containers 2.2%
Healthcare Facilities 1.4%
Healthcare Distributors 0.9%
Cash 1.5%
Total 100.0%
Geographic Exposure %
United States 46.2%
Switzerland 10.9%
Denmark 10.1%
Japan 7.3%
France 6.1%
Germany 3.5%
Belgium 3.3%
United Kingdom 2.9%
Netherlands 2.8%
Italy 2.3%
Sweden 2.1%
Ireland 0.9%
Cash 1.5%
Total 100.0%
The monthly factsheet will usually be available on the Company's website on
the 10(th) working day after the month end and includes a commentary by the
investment manager. www.Polarcapitalhealthcaretrust.co
(http://www.Polarcapitalhealthcaretrust.com) m
(http://www.Polarcapitalhealthcaretrust.com)
Neither the contents of the Company's website nor the contents of any website
accessible from the hyperlinks on the Company's website (or any other website)
is incorporated into or forms part of this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PFUZZGMZZGKGKZM
Recent news on Polar Capital Global Healthcare Trust